Although the comprehensive molecular mechanisms underlying TLC388-inducd antitumor immunity remain undetermined, we proposed that TLC388 promotes DC maturation by enhancing tumor antigen presentation through STING signaling and inducing immunogenic cell death such as HMGB1, ANXA1 and CRT [22]. The gene discussed is ANXA1; the disease is neoplasm.